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. Schematic representation of the experimental design applied in this study. The black zone represents the period of exposure of the dams to oil or to increasing doses of BPA: 5, 10 or 40 μg/kg BW/day. The fact that dosage was conducted via the oral route is indicated. The blue zone highlights the period for monitoring the age of vaginal opening. The age-points when euthanasia of the animals was applied and tissue sampling conducted are indicated with arrows. The tissues obtained for analyses are indicated: brain, for immunohistochemistry and in situ hybridization assays; and blood, for radioimmunoassay of LH and FSH levels. G: gestational day; PND: postnatal day; VO: vaginal opening; IHC: immunohistochemistry; ISH: in situ hybridization.
Figure S2.
Representative photomicrographs are shown of immunohistochemical (IHC) assays for detection of kisspeptin-immunoreactivity (Kp-IR) structures in the RP3V from female mice perinatally exposed to BPA 5, 10 or 40 μg/kg BW/day (BPA 5, 10 or 40 groups) at PND12, 15, 18, 21, and 30. An OIL-exposed group was used as a control. RP3V: Rostral periventricular area of the third ventricle; 3V: third ventricle. Figure S3 . Representative photomicrographs are shown of immunohistochemical (IHC) assays for detection of kisspeptin-immunoreactivity (Kp-IR) in the ARC from female mice perinatally exposed to BPA 5, 10 or 40 μg/kg BW/day (BPA 5, 10 or 40 groups) at PND12, 15, 18, 21, and 30. OIL-exposed group was used as a control. ARC: Arcuate nucleus; 3V: third ventricle. Figure S1 . Schematic representation of the experimental design applied in this study. The black zone represents the period of exposure of the dams to oil or to increasing doses of BPA: 5, 10 or 40 μg/kg BW/day. The fact that dosage was conducted via the oral route is indicated. The blue zone highlights the period for monitoring the age of vaginal opening. The age-points when euthanasia of the animals was applied and tissue sampling conducted are indicated with arrows. The tissues obtained for analyses are indicated: brain, for immunohistochemistry and in situ hybridization assays; and blood, for radioimmunoassay of LH and FSH levels. G: gestational day; PND: postnatal day; VO: vaginal opening; IHC: immunohistochemistry; ISH: in situ hybridization. Figure S2 . Representative photomicrographs are shown of immunohistochemical (IHC) assays for detection of kisspeptin-immunoreactivity (Kp-IR) structures in the RP3V from female mice perinatally exposed to BPA 5, 10 or 40 μg/kg BW/day (BPA 5, 10 or 40 groups) at PND12, 15, 18, 21, and 30. An OIL-exposed group was used as a control. RP3V: Rostral periventricular area of the third ventricle; 3V: third ventricle. Figure S3 . Representative photomicrographs are shown of immunohistochemical (IHC) assays for detection of kisspeptin-immunoreactivity (Kp-IR) in the ARC from female mice perinatally exposed to BPA 5, 10 or 40 μg/kg BW/day (BPA 5, 10 or 40 groups) at PND12, 15, 18, 21, and 30. OIL-exposed group was used as a control. ARC: Arcuate nucleus; 3V: third ventricle.
